Medicine

All Articles

Prenatal visibility to scarcity has an effect on long term health and wellness

.Nature Medication, Published online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of r...

A worldwide metric of invulnerable wellness

.Attribute Medication, Released online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A study mak...

Niacin, meals intake and also cardio results

.Attribute Medication, Published online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, fo...

Opportunities and problems for patient-reported end result analysis in multimorbidity research study as well as practice

.Contending passions.S.E.H. receives financing from the National Principle of Health and Care Resear...

Hibernation science harnessed to alleviate weight problems and change metabolic rate

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy knowing the...

CAR- T and also cell genetics therapies are actually too costly

.Nature Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care ma...

The that genomics course of help equitable application of individual genomics for international health and wellness

.The publication of the initial draft of the human genome sequence in 20011 was actually complied wi...

A time-stratified, case\u00e2 $ \"crossover study of warm direct exposure and also perinatal death coming from 16 hospitals in sub-Saharan Africa

.Amongst 138,015 hospital-based singleton births in 4 sub-Saharan African countries, our team notice...

Advancing worldwide antibiotic analysis, development as well as access #.\n\nMurray, C. J. L. et al. Global concern of bacterial antimicrobial protection in 2019: a systematic review. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. Towards certain devotions as well as activity in the action to antimicrobial protection. International Frontrunners Team on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Health Organization. WHO posts listing of germs for which new prescription antibiotics are actually urgently needed to have. World Health and wellness Organization https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Wellness Institution. WHO bacterial priority pathogens list, 2024: bacterial virus of hygienics usefulness to lead research, development as well as techniques to stop and control antimicrobial protection. Planet Wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entry. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nGlobe Wellness Company. 2023 anti-bacterial representatives in professional and preclinical advancement: a summary and also review. Globe Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Evaluation. May 19, 2016 \u00e2 $\" Handling drug-resistant infections globally: last document and also recommendations. Evaluation on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outputs: records as well as briefing. Drive AB https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall: an ask for concerted action on antibiotics r &amp d. Boston ma Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Brief 51: Just how can the EU support sustainable development and accessibility to reliable antibiotics? policy options for existing and new medicines. International Observatory on Wellness Solutions and Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Prescription antibiotic usage as well as resistance\u00e2 $\" proving the obvious. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Wellness Institution. 2021 Mindful distinction. WHO gain access to, check out, reserve, distinction of antibiotics for evaluation as well as surveillance of making use of. Planet Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Center for Condition Deterrence as well as Control. Antimicrobial protection aim ats: just how can our company reach them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Health And Wellness Association. Lack of technology readied to weaken antibiotic functionality and wellness gains. Globe Health Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. Just how antimicrobial protection is connected to environment improvement: a summary of two intertwined global challenges. Int. J. Environ. Res. Public Health 20, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant microbial infections: our team require urgent action and also investment that focus on the weakest web link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Association. Booster shot insurance coverage. Globe Health and wellness Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Disease deterrence as well as management in low-resource environments: the demand for the local area, the contextual and also the pragmatic. Corrupt. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Obstacles of carrying out antimicrobial conservation resources in low to mid revenue nations (LMICs). Contaminate. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A short record of the antibiotic period: trainings knew and also obstacles for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et cetera. Individual gain access to in 14 high-income countries to new antibacterials permitted due to the US Food and Drug Administration, European Medicines Company, Japanese Pharmaceuticals and Medical Tools Firm, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health Organization. 2021 anti-bacterial brokers in medical and also preclinical advancement: a summary and also review. World Wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the economics need to sustain the scientific research. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of development in anti-bacterial rehabs. Medical Technology Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Evaluating medical professional utilization of next-generation prescription antibiotics versus immune Gram-negative infections in USA medical centers: a retrospective accomplice research. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nThomas, D. &amp Wessel, C. The condition of technology in anti-bacterial therapies. Biotechnology Advancement Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A step-by-step assessment and important analysis of motivation approaches for exploration as well as progression of unfamiliar antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nWellness Emergency Situation Preparedness as well as Response Authority. Trial and error of health care countermeasures. European Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Payment. Pre-draft proposal for an European collaboration under Perspective Europe One Health And Wellness Antimicrobial Resistance. European Commission https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). International Antibiotic Experimentation Relationship. Entasis Therapies and also the Worldwide Prescription Antibiotic Research Study &amp Advancement Alliance to build a brand-new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of sector- and non-industry-sponsored clinical tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health And Wellness Association. Lot of clinical test signs up by location, disease, stage of growth, age as well as sexual activity of trial individuals (1999\u00e2 $ \"2022). Globe Health and wellness Association https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Antibiotic Research and Development Collaboration. NeoSept1: a research study to determine the ranking of existing and new prescription antibiotics mixtures to deal with newborn babies that remain in medical facility along with severe sepsis. ISRCTN computer system registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Company of Canada. Government of Canada brings in vital financial investment to combat antimicrobial resistance (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Anti-biotic R &amp D Collaboration. Asia government financing supports GARDP\u00e2 $ s attempts to resist antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Structure. Novo Nordisk Base partners with CARB-X to overcome drug-resistant infections. novo nordisk foundation https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Health and Digital Executive Agency. Study on delivering AMR clinical countermeasures to the market. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Determining the ideal size of international pull rewards for antibacterial medications. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entry perks for the progression of brand new anti-biotics. Harvard Kennedy School https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et cetera. Industry rewards as well as antibiotic protection: an introduction to the antibiotic sensitivity bonus. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An ambitious USG progressed dedication for subscription-based purchasing of novel antimicrobials and also its own expected roi. Center for Global Progression https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 expenditures in brand new antibiotics would certainly repay \u00e2 $\" for everyone. Workplace of Health and wellness Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS improves battle versus serious infections complying with productive world-first fly. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Compensation. Reform of the EU pharmaceutical legalisation. European Payment https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Repayment models to confront market failings for antimicrobials: methods enjoyed France, Germany, Sweden, the United Kingdom, and also the USA. Health and wellness Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Alliance of Drug Manufacturers and also Affiliations. From protection to strength: what could the potential antibiotic pipeline look like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Hub &amp Globe Wellness Company. Incentivising the progression of new antibacterial treatments: 2023 progress report by the Global AMR R&ampD Hub and also That. International AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Vocalist, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK registration style for antibiotics considered effective? Lancet Microbe 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimulations for the growth as well as going on the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, and nationwide reasons for child mortality in 2000\u00e2 $ \"13, with projections to notify post-2015 concerns: an upgraded systematic study. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et al. Antibacterial drug deficiencies from 2001 to 2013: effects for professional application. Clin. Corrupt. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et al. The French coverage body for drug scarcities: summary as well as fads coming from 2012 to 2018: an observational retrospective research study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Evaluation of WHO antibiotic consumption as well as get access to aim ats in 76 countries, 2000\u00e2 $ \"15: an evaluation of pharmaceutical purchases records. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Fighting the counterfeits: taking on subpar and also falsified medicines. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it receiving simpler to get prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nBlack Community for Lab Medication. Plan quick and infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic intake for individual usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Medication. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial consumption: review of central storehouses materials to in-patient treatment health and wellness amenities coming from 2017 to 2019 in Uganda. Trop. Med. Infect. Dis. 6, 83 (2021 ).\nGoogle.com Scholar\u00c2.\nRobertson, J. et al. Variations in the usage of antimicrobial medicines in the European region, 2014\u00e2 $ \"2018: searchings for and effects from ESAC-Net as well as WHO Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et cetera. Medication scarcity: sources, effect, and also mitigation methods. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Patient get access to in 14 high-income countries to brand new antibacterials accepted due to the United States Fda, European Medicines Firm, Japanese Pharmaceuticals as well as Medical Tools Firm, or Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et cetera. Lost antibiotics: a follow-up supply research in Europe, the United States, Canada as well as Australia. Int. J. Antimicrob. Representatives 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness advancement for international health and wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Market Collaboration. The 2023 AMR Market Alliance improvement questionnaire: manufacturing as well as the setting. amr Market Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Foray, D. &amp Gaule, P. Can medical items be developed on a charitable manner? Looking into item advancement partnerships for forgotten ailments. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et al. Reboot biomedical R&ampD in the worldwide social passion. Nature 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Health Condition Management as well as Avoidance. Africa CDC pioneers vibrant transfer to protect Africa\u00e2 $ s wellness future by producing a 50 billion dollar health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Blood, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Negotiating public-health intellectual property licensing deals to improve access to health modern technologies: an insider\u00e2 $ s account. BMJ Chunk. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New company models for experimentation along with price demands are actually required to obtain reasonable prices of medicines. Br. Medication. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Gas. Stewardship and also gain access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Global Antibiotic Research and Development Collaboration. Shinogi, GARDP and also CHAI declare site permit as well as cooperation deals to alleviate bacterial diseases by expanding access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Collaboration. Leaving behind the lab: tracking the decrease in AMR R&ampD experts. amr Field Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health And Wellness Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 call to action on antimicrobial resistance. G7G20 Records Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). Worldwide Union on Growing Old &amp Infectious Illness Society of United States. 2024 AMR preparedness mark report card. Gauging federal government action on AMR policy. Worldwide Coalition on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food and also Farming Association of the United Nations, United Nations Atmosphere Programme, World Health Organization &amp. World Organisation for Creature Health And Wellness. Worldwide data bank for tracking antimicrobial resistance (AMR): country self-assessment questionnaire (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Van Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in the ...

Integrating liver endpoints in scientific tests of cardio as well as renal disease

.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point...